跳至主要内容
临床试验/NL-OMON33236
NL-OMON33236
已完成
不适用

A comparison of the use of mini extracorporeal circuits with conventional extracorporeal circuits and with further miniaturized mini extracorporeal circuits in CABG patients. - A comparison of different extracorporeal circuits in CABG patients.

Maquet cardiopulmonary0 个研究点目标入组 150 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
1 coronary artery bypass surgery 2 atherosclesis
发起方
Maquet cardiopulmonary
入组人数
150
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Observational non invasive

研究者

发起方
Maquet cardiopulmonary

入排标准

入选标准

  • \* To have the right indication.
  • \* Body surface area between 1\.7 and 2\.0 m².
  • \* Age 20\-80\.
  • \* Pre\-operative normal sinus rhythm and AV\-conduction time.
  • \* Pre\- operative haemoglobin \> 6\.5 mmol/L.
  • \* Patient must be able to give written informed consent

排除标准

  • \* Transfusion of blood products shorter than seven days before the operation.
  • \* Re\- operations
  • \* Coagulation problems due to the use of thrombolytic agents less than 48 hours before the operation.
  • \* Thrombocytopenia (platelet count below 100,000 per ml)
  • \* Patient with hereditary hematological/ coagulation disorders
  • \* Insulin dependent diabetes
  • \* Using corticosteroid medication, use of corticosteroids before the surgery, or during the study period.
  • \* Emergency surgery
  • \* History of atrial fibrillation or other atrial arrhytmias eg (1 ° block, paroxysmal atrial tachycardia, atrial flutter)
  • \*Use of aspirin within 7 days or Plavix within 5 days or other anti platelet agents (including non steroid anti\-inflammatory medicaments) within 48 hours.

结局指标

主要结局

未指定

相似试验